Document Type

Article

Language

eng

Publication Date

2018

Publisher

American Chemical Society

Source Publication

Journal of Medicinal Chemistry

Source ISSN

0022-2623

Abstract

Estrogen receptor-beta (ERβ) is a drug target for memory consolidation in postmenopausal women. Herein is reported a series of potent and selective ERβ agonists (SERBAs) with in vivo efficacy that are A–C estrogens, lacking the B and D estrogen rings. The most potent and selective A–C estrogen is selective for activating ER relative to seven other nuclear hormone receptors, with a surprising 750-fold selectivity for the β over α isoform and with EC50s of 20–30 nM in cell-based and direct binding assays. Comparison of potency in different assays suggests that the ER isoform selectivity is related to the compound’s ability to drive the productive conformational change needed to activate transcription. The compound also shows in vivo efficacy after microinfusion into the dorsal hippocampus and after intraperitoneal injection (0.5 mg/kg) or oral gavage (0.5 mg/kg). This simple yet novel A–C estrogen is selective, brain penetrant, and facilitates memory consolidation.

Comments

Accepted version. Journal of Medicinal Chemistry, Vol 61, No. 11 (2018): 4720-4738. DOI. © 2018 American Chemical Society. Used with permission.

Download
donaldson_12752acc.docx (712 kB)
ADA accessible version

Included in

Chemistry Commons

Share

COinS